Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 26.96% vs 70.00% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 2,509.68% vs 91.32% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -189.19% vs 73.19% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -9.09% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Zevra Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 26.96% vs 70.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 488.64% vs -48.24% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 2,509.68% vs 91.32% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 475.38% vs -290.20% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -189.19% vs 73.19% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 51.80% vs -236.36% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -9.09% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.76% vs 950.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






